Development and characterization of a preclinical model of breast cancer lung micrometastatic to macrometastatic progression
about
Targeting dormant micrometastases: rationale, evidence to date and clinical implicationsA small molecule with anticancer and antimetastatic activities induces rapid mitochondrial-associated necrosis in breast cancer.Identification of novel drugs to target dormant micrometastasesInoculated Cell Density as a Determinant Factor of the Growth Dynamics and Metastatic Efficiency of a Breast Cancer Murine ModelA historic and scientific review of breast cancer: The next global healthcare challenge.Luciferase Expression Allows Bioluminescence Imaging But Imposes Limitations on the Orthotopic Mouse (4T1) Model of Breast Cancer.Discovery and preclinical evaluation of 7-benzyl-N-(substituted)-pyrrolo[3,2-d]pyrimidin-4-amines as single agents with microtubule targeting effects along with triple-acting angiokinase inhibition as antitumor agents.An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatment.MIND model for triple-negative breast cancer in syngeneic mice for quick and sequential progression analysis of lung metastasis.Alterations in NO- and PGI2- dependent function in aorta in the orthotopic murine model of metastatic 4T1 breast cancer: relationship with pulmonary endothelial dysfunction and systemic inflammation.Dual reporter genetic mouse models of pancreatic cancer identify an epithelial-to-mesenchymal transition-independent metastasis program
P2860
Q26765205-9E3F5D3A-4D9A-46E5-8536-47954552F125Q27345313-C5960202-A0B7-49A4-8258-3A06CC204B88Q28394296-BEF07784-D530-4B48-B347-A2C7705D2186Q36184480-EFB584D6-6E6B-47EE-8B07-5EAF9966822AQ38598415-068A4DA8-8F32-48D3-9CEF-3F2FD307559EQ38629732-71E84FDE-7850-42D9-A425-C259B4851F54Q38728583-49D0F3EB-D114-4B9A-B372-A009F4162774Q49262019-77699A0C-729A-4A1E-9CBC-C75C1EFE35D3Q54965481-A519CF11-BC0B-46BD-9BC5-F39424B3F88BQ55081573-88FEC81D-EF38-4453-BE65-0E08EE257A43Q58767409-1FA74390-F09E-4B2A-B555-6CDAB97ABC3A
P2860
Development and characterization of a preclinical model of breast cancer lung micrometastatic to macrometastatic progression
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Development and characterizati ...... to macrometastatic progression
@ast
Development and characterizati ...... to macrometastatic progression
@en
Development and characterizati ...... to macrometastatic progression
@nl
type
label
Development and characterizati ...... to macrometastatic progression
@ast
Development and characterizati ...... to macrometastatic progression
@en
Development and characterizati ...... to macrometastatic progression
@nl
prefLabel
Development and characterizati ...... to macrometastatic progression
@ast
Development and characterizati ...... to macrometastatic progression
@en
Development and characterizati ...... to macrometastatic progression
@nl
P2093
P2860
P3181
P1433
P1476
Development and characterizati ...... to macrometastatic progression
@en
P2093
Anja Bastian
Bryan C Disch
Jessica E Thorpe
Lora C Bailey-Downs
Michael A Ihnat
Paul J Hauser
Taleah Farasyn
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0098624
P407
P577
2014-01-01T00:00:00Z